Literature DB >> 16570856

Herpes simplex virus and the chemokines that mediate the inflammation.

D J J Carr1, L Tomanek.   

Abstract

Herpes simplex viruses (HSV) are highly pervasive pathogens in the human host with a seroconversion rate upwards of 60% worldwide. HSV type 1 (HSV-1) is associated with the disease herpetic stromal keratitis, the leading cause of infectious corneal blindness in the industrialized world. Individuals suffering from genital herpes associated with HSV type 2 (HSV-2) are found to be two- to threefold more susceptible in acquiring human immunodeficiency virus (HIV). The morbidity associated with these infections is principally due to the inflammatory response, the development of lesions, and scarring. Chemokines have become an important aspect in understanding the host immune response to microbial pathogens due in part to the timing of expression. In this paper, we will explore the current understanding of chemokine production as it relates to the orchestration of the immune response to HSV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570856      PMCID: PMC4076168          DOI: 10.1007/978-3-540-33397-5_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  105 in total

1.  Herpes simplex virus triggers and then disarms a host antiviral response.

Authors:  K L Mossman; P F Macgregor; J J Rozmus; A B Goryachev; A M Edwards; J R Smiley
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity.

Authors:  A M Harandi; B Svennerholm; J Holmgren; K Eriksson
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.

Authors:  P Härle; S Noisakran; D J Carr
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy.

Authors:  S Noisakran; P Härle; D J Carr
Journal:  Virology       Date:  2001-04-25       Impact factor: 3.616

5.  Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Authors:  M Mack; J Cihak; C Simonis; B Luckow; A E Proudfoot; J Plachý ; H Brühl; M Frink; H J Anders; V Vielhauer; J Pfirstinger; M Stangassinger; D Schlöndorff
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice.

Authors:  Ali M Harandi; Bo Svennerholm; Jan Holmgren; Kristina Eriksson
Journal:  J Gen Virol       Date:  2001-04       Impact factor: 3.891

7.  Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.

Authors:  S K Eo; S Lee; S Chun; B T Rouse
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts.

Authors:  Jeroen Maertzdorf; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

9.  Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10.

Authors:  Kaan Boztug; Monica J Carson; Ngan Pham-Mitchell; Valérie C Asensio; Julie DeMartino; Iain L Campbell
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

Review 10.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

View more
  31 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

Review 2.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 3.  Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

Authors:  Ronald J Mandel; Corinna Burger; Richard O Snyder
Journal:  Exp Neurol       Date:  2007-08-24       Impact factor: 5.330

4.  IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.

Authors:  Ana J Chucair-Elliott; Jeremy Jinkins; Meghan M Carr; Daniel J J Carr
Journal:  Am J Pathol       Date:  2016-08-03       Impact factor: 4.307

5.  Intact TRL 9 and type I interferon signaling pathways are required to augment HSV-1 induced corneal CXCL9 and CXCL10.

Authors:  Todd Wuest; Bobbie Ann Austin; Satoshi Uematsu; Manoj Thapa; Shizuo Akira; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2006-08-01       Impact factor: 3.478

6.  Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry.

Authors:  Christopher D O'Donnell; Maria Kovacs; Jihan Akhtar; Tibor Valyi-Nagy; Deepak Shukla
Journal:  Virology       Date:  2009-12-11       Impact factor: 3.616

7.  Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection.

Authors:  M Thapa; D J J Carr
Journal:  Open Immunol J       Date:  2008

8.  Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.

Authors:  Daniel J J Carr; Bobbie A Austin; William P Halford; Patrick M Stuart
Journal:  J Neuroimmunol       Date:  2008-11-29       Impact factor: 3.478

9.  Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide.

Authors:  Debora Pinna; Pasqua Oreste; Tiziana Coradin; Anna Kajaste-Rudnitski; Silvia Ghezzi; Giorgio Zoppetti; Antonella Rotola; Rafaela Argnani; Guido Poli; Roberto Manservigi; Elisa Vicenzi
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

10.  Herpes simplex virus type 2-induced mortality following genital infection is blocked by anti-tumor necrosis factor alpha antibody in CXCL10-deficient mice.

Authors:  Manoj Thapa; Daniel J J Carr
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.